About Contact Us Careers

Predisposition Biomarkers Market Size & Share, by Type (Molecular, Radiographic, Histologic, Physiologic); Application (Screening, Susceptibility Analysis, Diagnostic, Prognostic, Monitoring); End-Use (Hospitals, Research Institutes) - Global Supply & Demand Analysis, Growth Forecasts, Statistics Report 2025-2037

  • Report ID: 3090
  • Published Date: Dec 24, 2024
  • Report Format: PDF, PPT

Global Market Size, Forecast, and Trend Highlights Over 2025-2037

Predisposition Biomarkers Market size is expected to register remarkable growth rate during the forecast period i.e., between 2025-2037.

The growth of the market can be attributed to the various advantages provided by biomarkers in reducing and monitoring the risks of several acute and chronic disease, along with aid in diagnosis and treatment. The use of biomarkers, significantly reduces the healthcare expenditure, as it monitors the health beforehand, which is estimated to boost its demand throughout the forecast period. Moreover, the rising prevalence of diseases, such as, cancer, and diabetes along with increasing government initiatives to reduce the cases of such diseases, is anticipated to promote the market growth. According to the data by the WHO, over 422 million people around the world suffer from diabetes, and it causes about 1.6 million deaths every year. Furthermore, introduction of novel and advanced technologies, such as, digital biomarkers, and escalating adoption of personalized medicines is projected to boost the market growth.

Growth Drivers

  • Increasing Prevalence of Chronic Diseases, Such as, Cancer, and Diabetes
  • Advancement in Diagnostic Technology
  • Ease of Availability and Use of Biomarkers

Challenges

  • Lack of Efficient Healthcare System in Developing Countries

Access Detailed Forecasts & Data-Driven Insights: Request Free Sample PDF

Predisposition Biomarkers Segmentation

The market is segmented by application into screening, susceptibility analysis, diagnostic, prognostic, monitoring, and others, out of which, the diagnostic segment is anticipated to hold a notable share in the market during the forecast period on account of increasing incidences of late diagnosis of chronic diseases, which makes their treatment more complicated and riskier. Early diagnosis can eliminate such critical cases, and improve the success rate of the treatment.

Our in-depth analysis of the global market includes the following segments:

           Type
  • Molecular
  • Radiographic
  • Histologic
  • Physiologic

             Application
  • Screening
  • Susceptibility Analysis
  • Diagnostic
  • Prognostic
  • Monitoring
  • Others

 

 

           End-User
  • Hospitals
  • Research Institutes
  • Others
Vishnu Nair
Vishnu Nair
Head - Global Business Development

Customize this report to your requirements — connect with our consultant for personalized insights and options.

Predisposition Biomarkers Industry - Regional Synopsis

Regionally, the global predisposition biomarkers market is segmented into five major regions including North America, Europe, Asia Pacific, Latin America and Middle East & Africa region. North America industry is poised to account for largest revenue share by 2037, owing to undergoing advanced research and development in the healthcare sector along with innovative clinical experiments, and development of new diagnostic tools. The market in the Asia Pacific is estimated to witness notable growth accounting to the increasing geriatric population, along with increasing cases of various chronic diseases, such as, cancer, hypertension, and diabetes. Moreover, development in the healthcare sector, backed by government initiatives and increasing investment, is anticipated to boost the market growth.

Predisposition-Biomarkers-Market-Share
Get Strategic Analysis by Region Now: Request Free Sample PDF

Companies Dominating the Predisposition Biomarkers Landscape

    • Siemens Healthcare GmbH
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • Danaher Corporation
    • Biomarker Technologies, Inc.
    • Almac Group Limited
    • Myriad Genetics, Inc.
    • F. Hoffmann-La Roche Ltd
    • Epigenomics AG
    • Thermo Fisher Scientific Inc.
    • Bio-Rad Laboratories, Inc.
    • QIAGEN GmbH

Recent Developments

·   March 02, 2021: Myriad Genetics to join hands with Intermountain Precision Genomics to produce germline genetic testing services.

  • Report ID: 3090
  • Published Date: Dec 24, 2024
  • Report Format: PDF, PPT
  • Get detailed insights on specific segments/region
  • Inquire about report customization for your industry
  • Learn about our special pricing for startups
  • Request a demo of the report’s key findings
  • Understand the report’s forecasting methodology
  • Inquire about post-purchase support and updates
  • Ask About Company-Level Intelligence Additions

Have specific data needs or budget constraints?

customer-service Inquiry Before Buying

Frequently Asked Questions (FAQ)

Predisposition Biomarkers Market size is expected to register remarkable growth rate during the forecast period i.e., between 2025-2037.

Rising prevalence of the acute and chronic disease, and growing R&D investment for medical research will impel the market growth.

North America industry is poised to account for largest revenue share by 2037, owing to undergoing advanced research and development in the healthcare sector along with innovative clinical experiments, and development of new diagnostic tools.

The major players in the market are Danaher Corporation, Biomarker Technologies, Inc., Almac Group Limited, Myriad Genetics, Inc., F. Hoffmann-La Roche Ltd, Epigenomics AG, Thermo Fisher Scientific Inc., Bio-Rad Laboratories, Inc., QIAGEN GmbH and others.

Predisposition Biomarkers Market Report Scope

GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

Connect with our Expert

Radhika Pawar
Radhika Pawar
Senior Research Analyst
Get a Free Sample

See how top U.S. companies are managing market uncertainty — get your free sample with trends, challenges, macroeconomic factors, charts, forecasts, and more.

Inquiry Before Buying Request Free Sample PDF

Copyright @ 2025 Research Nester. All Rights Reserved.

footer-bottom-logos